CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 41 filers reported holding CTI BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $15,000 | -67.4% | 12,573 | -74.9% | 0.00% | – |
| Q1 2020 | $46,000 | -41.8% | 50,073 | 0.0% | 0.00% | – |
| Q4 2019 | $79,000 | +88.1% | 50,073 | 0.0% | 0.00% | – |
| Q3 2019 | $42,000 | -2.3% | 50,073 | 0.0% | 0.00% | – |
| Q2 2019 | $43,000 | -12.2% | 50,073 | 0.0% | 0.00% | – |
| Q1 2019 | $49,000 | +32.4% | 50,073 | 0.0% | 0.00% | – |
| Q4 2018 | $37,000 | -66.7% | 50,073 | -2.9% | 0.00% | – |
| Q3 2018 | $111,000 | -56.8% | 51,573 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $257,000 | +25.4% | 51,573 | -1.9% | 0.00% | 0.0% |
| Q1 2018 | $205,000 | +135.6% | 52,598 | +61.5% | 0.00% | – |
| Q4 2017 | $87,000 | -16.3% | 32,573 | 0.0% | 0.00% | – |
| Q3 2017 | $104,000 | +1055.6% | 32,573 | +1166.0% | 0.00% | – |
| Q2 2017 | $9,000 | -81.6% | 2,573 | -78.0% | 0.00% | – |
| Q1 2017 | $49,000 | – | 11,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,800,358 | $21,825,000 | 10.02% |
| CAXTON CORP | 2,239,300 | $5,553,000 | 4.54% |
| Altium Capital Management LP | 2,185,000 | $5,419,000 | 1.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,483,829 | $3,680,000 | 1.49% |
| Ghost Tree Capital, LLC | 1,200,000 | $2,976,000 | 1.07% |
| Lion Point Capital, LP | 1,223,595 | $3,034,000 | 0.81% |
| BVF INC/IL | 8,929,690 | $22,146,000 | 0.80% |
| NEA Management Company, LLC | 7,140,450 | $17,708,000 | 0.36% |
| Knott David M Jr | 221,079 | $548,000 | 0.19% |
| Lakeside Advisors, INC. | 97,780 | $242,000 | 0.18% |